| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |